首页> 外文期刊>Diagnostic pathology >Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer
【24h】

Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer

机译:关于半自动图像分析软件在乳腺癌中雌激素和孕激素受体检测中应用的验证的技术说明

获取原文
       

摘要

Background The immunohistochemical detection of estrogen (ER) and progesterone (PR) receptors in breast cancer is routinely used for prognostic and predictive testing. Whole slide digitalization supported by dedicated software tools allows quantization of the image objects (e.g. cell membrane, nuclei) and an unbiased analysis of immunostaining results. Validation studies of image analysis applications for the detection of ER and PR in breast cancer specimens provided strong concordance between the pathologist's manual assessment of slides and scoring performed using different software applications. Methods The effectiveness of two connected semi-automated image analysis software (NuclearQuant v. 1.13 application for Pannoramic? Viewer v. 1.14) for determination of ER and PR status in formalin-fixed paraffin embedded breast cancer specimens immunostained with the automated Leica Bond Max system was studied. First the detection algorithm was calibrated to the scores provided an independent assessors (pathologist), using selected areas from 38 small digital slides (created from 16 cases) containing a mean number of 195 cells. Each cell was manually marked and scored according to the Allred-system combining frequency and intensity scores. The performance of the calibrated algorithm was tested on 16 cases (14 invasive ductal carcinoma, 2 invasive lobular carcinoma) against the pathologist's manual scoring of digital slides. Results The detection was calibrated to 87 percent object detection agreement and almost perfect Total Score agreement (Cohen's kappa 0.859, quadratic weighted kappa 0.986) from slight or moderate agreement at the start of the study, using the un-calibrated algorithm. The performance of the application was tested against the pathologist's manual scoring of digital slides on 53 regions of interest of 16 ER and PR slides covering all positivity ranges, and the quadratic weighted kappa provided almost perfect agreement (κ = 0.981) among the two scoring schemes. Conclusions NuclearQuant v. 1.13 application for Pannoramic? Viewer v. 1.14 software application proved to be a reliable image analysis tool for pathologists testing ER and PR status in breast cancer.
机译:背景技术乳腺癌中雌激素(ER)和孕激素(PR)受体的免疫组织化学检测常规用于预后和预测性测试。专用软件工具支持的完整载玻片数字化功能可对图像对象(例如细胞膜,细胞核)进行量化,并进行免疫染色结果的无偏分析。图像分析应用程序用于检测乳腺癌标本中的ER和PR的验证研究在病理学家对载玻片的手动评估和使用不同软件应用程序进行的评分之间提供了高度的一致性。方法两套相连的半自动图像分析软件(NuclearQuant v.13在Pannoramic?Viewer v.1.14上的应用)对用自动化Leica Bond Max系统免疫染色的福尔马林固定石蜡包埋的乳腺癌标本中ER和PR状态测定的有效性被研究了。首先,使用来自38个小型数字幻灯片(由16个案例创建)中选择的区域(包含平均195个细胞)选择区域,将检测算法校准为由独立评估者(病理学家)提供的分数。手动标记每个细胞,并根据结合频率和强度评分的Allred系统对细胞进行评分。对照病理学家对数字幻灯片的手动评分,在16例(14例浸润性导管癌,2例浸润性小叶癌)中测试了校准算法的性能。结果使用未校准的算法,从研究开始时的轻微或中度一致性,将检测结果校准为87%的对象检测一致性和几乎完美的总分一致性(Cohen kappa 0.859,二次加权kappa 0.986)。对照病理学家在16个ER和PR载玻片的53个感兴趣区域上覆盖所有阳性范围的数字载玻片,对应用程序的性能进行了测试,并且二次加权kappa在两种评分方案中提供了几乎完美的一致性(κ= 0.981) 。结论NuclearQuant v.1.13适用于Pannoramic? Viewer v.14软件应用程序被证明是病理学家测试乳腺癌ER和PR状态的可靠图像分析工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号